BND-35
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
BND-35 is a human monoclonal antibody (mAb) that targets LILRB4/ILT3/CD85k. It interferes with the interaction between ILT3 and APOE as well as fibronectin, thereby enhancing the pro-inflammatory activity of various myeloid cells and reversing T cell immunosuppression mediated by different inhibitory myeloid cells. BND-35 exhibits antitumor activity in hILT3 transgenic mouse tumor models.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1345062-01 0.05 mg (E-Coli)
Recombinant Australian bat lyssavirus Matrix protein (M)
Ask
View Details MBS1345062-02 0.05 mg (Yeast)
Recombinant Australian bat lyssavirus Matrix protein (M)
Ask
View Details MBS1345062-03 0.2 mg (E-Coli)
Recombinant Australian bat lyssavirus Matrix protein (M)
Ask
View Details